Ciclopirox 0.0077 MG/MG Topical Gel — RxCUI 313941
RxNorm drug concept · Semantic clinical drug
RxCUI 313941
Semantic clinical drug · SCD
● Current RxNorm concept 7 FDA products
13 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI313941
Official nameCiclopirox 0.0077 MG/MG Topical Gel
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asciclopirox 0.77 % Topical Gel; ciclopirox 0.77 % (ciclopirox olamine 1 % ) Topical Gel
FDA products mapped7
Package NDCs mapped13
Reported Medicaid activity (SDUD)3,963 prescriptions · 13 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Ciclopirox Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Fungal nail infections are slow to clear, and Ciclodan nail lacquer is no exception. In clinical studies, treatment lasted up to 48 weeks. Only a small percentage of patients achie...
- How long does it take for the nail lacquer to work?
- No — that's actually one of the most important things to get right. You apply Ciclodan once a day and leave it on. Each new coat goes right on top of the previous one. After seven...
- Do I need to remove the nail lacquer every night before I apply a new coat?
🕸️ Concept Web — How Ciclopirox 0.0077 MG/MG Topical Gel Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Ciclopirox 0.0077 MG/MG Topical Gel
RxCUI 313941 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Ciclopirox
21090IN
-
Ciclopirox
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Ciclopirox Topical Gel
378069SCDF -
Ciclopirox Topical Product
1163131SCDG -
Topical Gel
346286DF -
Topical Product
1151122DFG
-
Ciclopirox Topical Gel
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Ciclopirox 0.0077 MG/MG
329435SCDC
-
Ciclopirox 0.0077 MG/MG
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Ciclopirox 0.0077 MG/MG
SCDC · 329435 -
Ciclopirox Topical Gel
SCDF · 378069 -
Ciclopirox Topical Product
SCDG · 1163131
📦 FDA Products & Package NDCs
7 products · 13 package NDCs
13 package NDCs map to RxCUI 313941 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-2061-01 | 1 TUBE in 1 CARTON (0574-2061-01) / 100 g in 1 TUBE | CICLOPIROX | Padagis US LLC | 2009-01-07 |
| 00574-2061-30 | 1 TUBE in 1 CARTON (0574-2061-30) / 30 g in 1 TUBE | CICLOPIROX | Padagis US LLC | 2009-01-07 |
| 00574-2061-45 | 1 TUBE in 1 CARTON (0574-2061-45) / 45 g in 1 TUBE | CICLOPIROX | Padagis US LLC | 2009-01-07 |
| 63629-8620-01 | 1 TUBE in 1 CARTON (63629-8620-1) / 30 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2009-01-07 |
| 63629-8621-01 | 1 TUBE in 1 CARTON (63629-8621-1) / 45 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2009-01-07 |
| 63629-8622-01 | 1 TUBE in 1 CARTON (63629-8622-1) / 100 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2009-01-07 |
| 68462-0455-35 | 30 g in 1 TUBE (68462-455-35) | ciclopirox | Glenmark Pharmaceuticals Inc., USA | 2012-02-29 |
| 68462-0455-47 | 45 g in 1 TUBE (68462-455-47) | ciclopirox | Glenmark Pharmaceuticals Inc., USA | 2012-02-29 |
| 68462-0455-94 | 100 g in 1 TUBE (68462-455-94) | ciclopirox | Glenmark Pharmaceuticals Inc., USA | 2012-02-29 |
| 71335-2757-01 | 30 g in 1 TUBE (71335-2757-1) | ciclopirox | Bryant Ranch Prepack | 2025-08-08 |
| 72162-1126-01 | 1 TUBE in 1 CARTON (72162-1126-1) / 100 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2024-03-11 |
| 72162-1126-02 | 1 TUBE in 1 CARTON (72162-1126-2) / 45 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2024-03-11 |
| 72162-1126-03 | 1 TUBE in 1 CARTON (72162-1126-3) / 30 g in 1 TUBE | CICLOPIROX | Bryant Ranch Prepack | 2024-03-11 |
Observed labelers:
Bryant Ranch Prepack (7) ·
Glenmark Pharmaceuticals Inc., USA (3) ·
Padagis US LLC (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.8463
Range $0.8371–$0.9190
· middle 50% $0.8394–$0.9008
· 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.